ALX Oncology
ALXO
ALXO
106 hedge funds and large institutions have $510M invested in ALX Oncology in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.39% less ownership
Funds ownership: 92.69% → 91.3% (-1.4%)
26% less capital invested
Capital invested by funds: $688M → $510M (-$177M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
106
Holding in Top 10
2
Calls
$1.58M
Puts
$400K
Top Buyers
| 1 | +$10.6M | |
| 2 | +$7.44M | |
| 3 | +$1.23M | |
| 4 |
Squarepoint
New York
|
+$1.19M |
| 5 |
Goldman Sachs
New York
|
+$739K |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$5.74M | |
| 3 | -$5.4M | |
| 4 |
O
OrbiMed
New York
|
-$4.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.46M |